| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |